{"id":13364,"date":"2021-05-11T17:52:16","date_gmt":"2021-05-11T15:52:16","guid":{"rendered":"https:\/\/profertil.eu\/?page_id=13364"},"modified":"2023-10-09T11:20:42","modified_gmt":"2023-10-09T09:20:42","slug":"estudio-de-l-carnitina-2016","status":"publish","type":"page","link":"https:\/\/profertil.eu\/es\/estudios\/estudio-de-l-carnitina-2016\/","title":{"rendered":"Estudio de L-carnitina 2016"},"content":{"rendered":"\n
\"\"
\n

COMPOSICI\u00d3N
EXCEPCIONAL<\/span><\/h1>\n<\/div><\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n

\u00bbGracias al efecto sin\u00e9rgico, la f\u00f3rmula patentada de PROFERTIL\u00ae<\/sup> es claramente superior a la ingesta de altas dosis de L-carnitina.\u00ab <\/p>\n\n\n\n

<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n
<\/div>\n\n\n\n

ESTUDIO DE L-CARNITINA 2016<\/p>\n\n\n\n

Cambio relativo en los par\u00e1metros del esperma (en un %) despu\u00e9s de tres meses tomando PROFERTIL\u00ae<\/sup> vs. un grupo<\/strong><\/h3>\n<\/div>\n\n\n\n
\n
\"\"<\/figure><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

N\u00famero de pacientes<\/strong>:
<\/strong>n = 299
(Grupo PROFERTIL\u00ae<\/sup>: n = 143;
grupo de control: n = 156)

Publicaci\u00f3n<\/strong>:
<\/strong>Reprod Biol Endocrin (diciembre 2016) 14:84.<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
El primer estudio prospectivo controlado (comparado con altas dosis de L-carnitina) ha mostrado la superioridad de la composici\u00f3n de PROFERTIL\u00ae:<\/strong><\/h6>\n\n\n\n